PHOENIX, April 17, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest^®, recently concluded participation at New York's Rodent Roundup.

The New York Pest Management's (NYPMA) Rodent Spring Conference is a one-of-a-kind event dedicated to providing a day of education and technology for the pest management industry. With its unique focus on providing a forum for attendees to learn from each other about their technology experiences as well as current technologies used to enhance daily practices within their pest management businesses, this conference is a prime opportunity to showcase services and products and promote awareness of the brand to top-level decision-makers from the pest management industry and government.

Joel Fruendt, SenesTech's CEO, attended this conference along with SenesTech's sales team, highlighting the importance of bringing ContraPest to New York City as Kathleen Corradi, the City's new Director of Rodent Mitigation, and her team are preparing their new integrated pest management plan.

"The conference had great participation from the industry and from the city. We talked to local pest management leaders as well as representatives from the New York Housing Authority and Parks Department," said Joel Fruendt, SenesTech's CEO. "These comments were repeated time and time again as participants were introduced to ContraPest:"

"This is a great solution to reduce the rat population without negatively affecting the environment."
"We need an aggressive pro-active plan to stop reproduction."
"My customers will love that this provides less risk for their business and brand."
"This will work great in areas that suffer from sanitation issues."
"It is so easy to set up and service."
"I have a few customers that could benefit from ContraPest today."
"I can't think of anyone in NYC who could not benefit from the use of ContraPest."
"It is more affordable than I had heard."
"It is great that you can now ship directly into NY."

"We are eager to help the new Rat Czar in addressing New York's rat crisis in an effective and earth-friendly manner, and these comments from local pest management professionals certainly should help," added Mr. Fruendt.

About SenesTech
We are the experts in rat fertility control. Our passion is to create a healthy environment by better controlling rat pest populations. We keep an inescapable truth in mind. Two rats and their descendants can be responsible for the birth of up to 15,000 pups after a year. We invented ContraPest, the only U.S. EPA registered contraceptive for male and female rats. ContraPest fits seamlessly into all integrated pest management programs, greatly improving the overall goal of effective rat management. We strive for clean cities, efficient businesses, and happy households – with a product that was designed to be effective and sustainable without killing rats. At SenesTech, we are committed to improving the health of the world by humanely managing animal populations through fertility control.

For more information visit https://senestech.com/ and https://contrapeststore.com. 

Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that the NYPMA Rodent Spring Conference is a prime opportunity to showcase services and products and promote awareness of the brand to top-level decision-makers from the pest management industry and government; and our eagerness to help the new Rat Czar in addressing New York's rat crisis in an effective and earth-friendly manner, and our belief the comments from local pest management professionals certainly should help. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the impacts and implications of the COVID-19 pandemic, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT: 
Investors: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC,
602-889-9700, senestech@lythampartners.com

Press: Nicole Williams, Chief Revenue Officer, SenesTech, Inc., 928-779-4143

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,
928-779-4143

SOURCE SenesTech, Inc.